Lethal hypocrisy of US Special 301 Report

Patent protection in the US is a convoluted and expensive business and yet it pulls up other countries that have robust systems

डाउन टू अर्थ खास: जीआई टैग को बढ़ावा देने से किसे होगा फायदा?

जीआई टैग अथवा भौगोलिक संकेतकों की संख्या बढ़ाने के लिए �…

When generics turn into Big Pharma

Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims  

Bedaquiline patent win is a half victory

India’s ability to eliminate its huge TB burden by 2025 will be a test of both its patent laws and healthcare policy

Fading history of Novartis v Union of India

The 2013 landmark Supreme Court judgement offers critical lessons on the intent behind crucial aspects of India’s key patent law

Why the move to foist a GI tag on Mandu’s baobab tree is a no-brainer

Commerce ministry’s drive to push up the Geographical Indications tally is a lazy exercise that does not benefit local communities

Why Americans pay more for prescription drugs than anywhere else globally

The root of the problem is a patent system that allows pharma companies to keep out competition and keep prices sky high

GM Mustard, Joshimath: Gagging scientists is a lousy idea; here’s why

Science needs to be open; the silencing of experts by the Modi regime on critical issues is against the public interest

Pharma’s dirty deals to stall generics

As generic companies, including Indian firms, collude with innovator pharma giants in pay-for-delay pacts, consumers pay a high price

Cuetlaxochitl: The story of America’s Christmas Eve shrub has lessons for free trade, patents  

Poinsettia can be an example of intellectual property rights or biopiracy; it depends on whose interests one wants to nourish and protect: the …

Henrietta Lacks: The troubling legacy of a Black woman’s cells

Ethical concerns over her cells, the most widely used in research, are in the spotlight as family seeks reparation

India is patently way behind on 5G

Policy blocks and poor vision have held up 5G in India, while China’s breakthroughs are helping to set global standards

Desperate writ petitions of dying patients

Cancer, TB patients are urging a reluctant government to use compulsory licences to make life-saving drugs accessible

Moderna strikes with a new lawsuit

Moderna is trying to be gatekeeper for the mRNA platform for future drug development, raising monopolistic fears

क्या कोविड-19 टीके का किस्सा खत्म?

भारत का दावा है कि कोविड-19 के खिलाफ लड़ाई में टीका अब कोई �…

A COVID-19 encore with monkeypox

A familiar pattern is emerging in the battle against monkeypox with the US and Europe grabbing scarce vaccine supplies

Is the COVID-19 vaccine story over?

India claims vaccines are no longer an issue in the battle against COVID-19, but a host of developing nations would disagree

Only a piglet in Russia’s war on patents

Post-Ukraine, Russia has held back from appropriating intellectual property despite a law to punish unfriendly countries

India finally gives in on TRIPS waiver

The WTO agreement on a limited patents waiver merely restates exemptions already available under existing rules

Charity after profiteering, the Big Pharma way

Pfizer to sell its medicines at no profit in world’s poorest countries, and other big names to make cancer drugs more accessible

Food for all to free for all: The collateral of Russia vs Ukraine

Russia-Ukraine war has razed global agriculture system, once sold as the magic formula. It led to concentration of food production in a few …

Food for all to free for all: Unconcerned WTO make matters worse

This is the second part to the report ‘Food for all to free for all: The collateral of Russia vs Ukraine’  

Intellectual Property: Why is India silent, as a compromise deal on COVID-19 therapies is worked out

The fact is, Indian and South African interests have diverged; India is not in desperate need of vaccines anymore and hence does not want to …

Will Biden dare to use march-in rights?

Health advocates are asking Washington to use laws that allow patent override on drugs developed with public funds

In the midst of war, Russia hits at patents

As US-EU sanctions deepen, Moscow passes a law to allow free use of patents owned by ‘unfriendly countries’